UNSPSC 51422317: Fluclorolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H25Cl2FO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 036B9W83KK, chemically known as 9,11beta-dichloro-6alpha-fluoro-16alpha,17,21-trihydroxypregna-1,4-diene-3,20-dione but generally known as fluclorolone, which bears US NIH Compound Identifier 20054914. European Medicines Agency schedules Fluclorolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07672MIG.

The term FLUCLOROLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). As of Q4 2014, FLUCLOROLONE remains the US FDA Preferred Term for this commodity. SMILES: CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)Cl)Cl)C)F)C.

UNSPSC 51422317 Fluclorolone (Commodity) does not align with the recent state and local procurement activity tagged under this code. The two opportunities present—a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs—involve naloxone distribution, pharmacy benefit management, and therapeutic initiatives rather than fluclorolone, a topical corticosteroid pharmaceutical ingredient. The code's nominal scope and the work actually being solicited diverge materially, suggesting either a tagging misclassification in the source data or insufficient recent activity to establish a meaningful market signal under this specific commodity code.

The source provides no other recent state and local solicitations under UNSPSC 51422317, and does not support characterization of issuing-body mix, geographic concentration, or representative activity grounded in fluclorolone procurement. Firms evaluating this code should verify the correct UNSPSC classification for their target product category or monitor for corrected opportunities in future cycles.